Search - Prime Therapeutics

411 Results for GLP-1 Pipeline Update

Prime/MRx experts share clinical insights for migraine treatment

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

Prime Article: Stories
FDA Decisions Expected: July 2025

PUBLICATIONS FDA Decisions Expected: July 2025 Your monthly synopsis of new drugs expected to hit the market June 18, 2025 Drug pipeline for July 2025 At Prime Therapeutics (Prime), we have...
High-Cost Therapy Profile: March

Perspectives High-Cost Therapy Profile: March Detailed information about Sotatercept Subcutaneous (SC) High Cost Therapy Profile Cardiovascular Sotatercept Subcutaneous (SC) Merck/Bristol-Myers...
Recapping Prime’s 21st annual Specialty Summit

Marquee event showcased new Prime, our energy, ambition and transformative journey

PA Sub-Categories: Specialty drugs Prime Article: Perspectives